Clinical Trial Update: Diphenylcyclopropenone (DPCP) as a Depigmenting Therapy in Extensive Vitiligo [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing Diphenylcyclopropenone (DPCP) as a depigmenting therapy for extensive vitiligo completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• Diphenylcyclopropenone (diphenylcyclopropenone)

Snippet

Sponsor: Ain Shams University | Conditions: Vitiligo | Phase 4 | Status: COMPLETED